Literature DB >> 12084501

Optimisation of carbomer viscous eye drops: an in vitro experimental design approach using rheological techniques.

Jens Ceulemans1, Annick Ludwig.   

Abstract

The optimisation of the in vitro interaction between several poly(acrylic acid) derivatives (Carbopol 1342P NF, Carbopol 974P and Carbopol 980 NF) and mucin was performed by an analysis technique combining oscillatory shear rheology and experimental design in order to improve the formulation of carbomer viscous eye drops.First, standard oscillation procedures were used to characterise the polyacrylic acid and mucin dispersions, and to investigate the influence of several polymer-related factors (concentration, preparation, type of polymer used) on the rheological properties. Second, an experimental plan design was developed to investigate the effect of polymer-related factors on the mucoadhesive indexes (MAI(G') and MAI(G")) which were calculated using the viscoelastic data obtained from polymer/mucin, polymer/tearfluid and mucin/tearfluid mixtures. Optimal mucoadhesive interactions were determined based on the experimental design results. Finally, the optima were fully characterised rheologically to further verify the mucoadhesive capacity. The main conclusion is that the factor influencing most explicitly the mucoadhesive interaction of the viscous eye drop is the mucin concentration and neither the type of polyacrylic acid, nor its concentration.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12084501     DOI: 10.1016/s0939-6411(02)00036-x

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  9 in total

Review 1.  In vitro and ex vivo corneal penetration and absorption models.

Authors:  Priyanka Agarwal; Ilva D Rupenthal
Journal:  Drug Deliv Transl Res       Date:  2016-12       Impact factor: 4.617

2.  Preparation and characterization of pluronic-colloidal silicon dioxide composite particles as liquid crystal precursor.

Authors:  Manish Maheshwari; Anant Paradkar; Shigeo Yamamura; Shivajirao Kadam
Journal:  AAPS PharmSciTech       Date:  2006       Impact factor: 3.246

3.  Development of an ex vivo method for evaluation of precorneal residence of topical ophthalmic formulations.

Authors:  Quan Liu; Youmin Wang
Journal:  AAPS PharmSciTech       Date:  2009-06-12       Impact factor: 3.246

4.  Enhanced bioavailability of L-carnitine after painless intradermal delivery vs. oral administration in rats.

Authors:  Suohui Zhang; Guangjiong Qin; Yan Wu; Yunhua Gao; Yuqin Qiu; Fang Li; Bai Xu
Journal:  Pharm Res       Date:  2010-04-13       Impact factor: 4.200

5.  Cross-linked poly(acrylic acids) microgels and agarose as semi-interpenetrating networks for resveratrol release.

Authors:  Marta Tunesi; Elisabetta Prina; Fabiola Munarin; Serena Rodilossi; Diego Albani; Paola Petrini; Carmen Giordano
Journal:  J Mater Sci Mater Med       Date:  2015-01-11       Impact factor: 3.896

Review 6.  Nanomedicines for back of the eye drug delivery, gene delivery, and imaging.

Authors:  Uday B Kompella; Aniruddha C Amrite; Rashmi Pacha Ravi; Shelley A Durazo
Journal:  Prog Retin Eye Res       Date:  2013-04-17       Impact factor: 21.198

7.  Wettability and contact angle affect precorneal retention and pharmacodynamic behavior of microspheres.

Authors:  Hanyu Liu; Xinyue Han; Huamei Li; Qi Tao; Jie Hu; Shuo Liu; Huaixin Liu; Jun Zhou; Wei Li; Fan Yang; Qineng Ping; Shijie Wei; Hongmei Liu; Huaqing Lin; Dongzhi Hou
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.819

8.  Drug-peptide supramolecular hydrogel boosting transcorneal permeability and pharmacological activity via ligand-receptor interaction.

Authors:  Lin Chen; Jie Deng; Ailing Yu; Yuhan Hu; Bo Jin; Pengyuan Du; Jianhong Zhou; Lei Lei; Yuan Wang; Serhii Vakal; Xingyi Li
Journal:  Bioact Mater       Date:  2021-09-10

9.  The Effect of Artificial Tear Preparations with Three Different Ingredients on Contrast Sensitivity in Patients with Dry Eye Syndrome.

Authors:  Sezen Akkaya
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2018
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.